Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Silvia Koder"'
Autor:
Cornelia Englisch, Florian Moik, Johannes Thaler, Silvia Koder, Nigel Mackman, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Venous thromboembolism (VTE) is a common complication in patients with cancer. Data on the role of natural inhibitors of coagulation for occurrence of cancer-associated VTE are limited, thus, we investigated the association of tissue factor pathway i
Externí odkaz:
https://doaj.org/article/70622f744d904a23ac4e6d653ee1fe29
Autor:
Lena Hell, Kristina Lurger, Lisa-Marie Mauracher, Ella Grilz, Christina Maria Reumiller, Georg Johannes Schmidt, Huriye Ercan, Silvia Koder, Alice Assinger, José Basilio, Johanna Gebhart, Cihan Ay, Ingrid Pabinger, Maria Zellner
Publikováno v:
Experimental and Molecular Medicine, Vol 52, Iss 1, Pp 66-78 (2020)
Blood coagulation: Protein changes in platelets linked to thrombosis People at high risk for thrombosis (formation of a blood clot inside a blood vessel) show alterations in their platelet protein content. Lena Hell, Maria Zellner, Ingrid Pabinger an
Externí odkaz:
https://doaj.org/article/aa29f0c346ad4662bef50def48e4cc01
Autor:
Hanna L. Obermeier, Julia Riedl, Cihan Ay, Silvia Koder, Peter Quehenberger, Rupert Bartsch, Alexandra Kaider, Christoph C. Zielinski, Ingrid Pabinger
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 503-514 (2019)
Abstract Essentials Cancer is associated with increased risk of developing venous thrombosis. Cancer patients were studied for ADAMTS‐13 and VWF levels and occurrence of venous thrombosis. Increased VWF in cancer patients is associated with a highe
Externí odkaz:
https://doaj.org/article/c6bc5c87ba764a30ba94aef60f815d6d
Autor:
Cihan Ay, Ingrid Pabinger, Christoph Zielinski, Silvia Koder, Oliver Königsbrügge, Gerhard-Johann Zlabinger, Johannes Thaler, Florian Posch
Purpose: Cancer patients are at an increased risk of venous thromboembolism (VTE). VEGF promotes the growth of highly thrombogenic tumor vessels. Here, we explored the utility of soluble plasma VEGF-A (sVEGF) as a biomarker for the prediction of VTE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0192e3f68f8a83969725aa448e7a6125
https://doi.org/10.1158/1078-0432.c.6524850.v1
https://doi.org/10.1158/1078-0432.c.6524850.v1
Autor:
Cihan Ay, Ingrid Pabinger, Christoph Zielinski, Silvia Koder, Oliver Königsbrügge, Gerhard-Johann Zlabinger, Johannes Thaler, Florian Posch
Table S1: Mean change in sVEGF according to selected variables - Simple linear regression models Table S2: Mean change in sVEGF* according to selected variables - "Multiple Model 1" Table S3: Mean change in sVEGF according to selected variables - "Mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c33a89c6cda1e3249b122a3becc8861
https://doi.org/10.1158/1078-0432.22461657.v1
https://doi.org/10.1158/1078-0432.22461657.v1
Autor:
Johanna Roiß, Thomas M. Hofbauer, Ingrid Pabinger, Lisa-Marie Mauracher, Christine Brostjan, Johanna Gebhart, Hubert Hayden, Lena Hell, Silvia Koder, Moritz Krall, Cihan Ay
Publikováno v:
Rheumatology (Oxford, England)
Objectives Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil e
Autor:
Meaghan E. Colling, Cihan Ay, Daniel Kraemmer, Silvia Koder, Peter Quehenberger, Ingrid Pabinger, Florian Posch, Johanna Gebhart
Publikováno v:
Blood advances. 6(10)
Data on lupus anticoagulant (LA) test stability in patients persistently positive for LA are limited, and its implications on clinical outcomes are lacking. We investigated the rate and predictors of a negative LA test and whether experiencing a nega
Autor:
Helmuth Haslacher, Stefanie Hofer, Alisa S. Wolberg, Johanna Gebhart, Ingrid Pabinger, Judit Rejtö, Cihan Ay, Silvia Koder
Publikováno v:
Journal of Thrombosis and Haemostasis
Background In a large proportion of patients with a mild to moderate bleeding tendency no diagnosis can be established (bleeding of unknown cause, BUC). Objectives To investigate possible dysfunctions in thrombin generation and plasma clot formation
Autor:
Maria Zellner, Johanna Gebhart, José Basílio, Alice Assinger, Silvia Koder, Georg Johannes Schmidt, Lena Hell, Ingrid Pabinger, Lisa-Marie Mauracher, Christina Maria Reumiller, Cihan Ay, K. Lurger
Publikováno v:
Science meets clinical practice.
Publikováno v:
Clinical and Experimental Medicine
The thrombin generation potential is an in vitro measure for the capacity of an individual to generate thrombin and recognized as a reflection of a hypo- or hypercoagulable status. Measurement of the in vivo thrombin activity, however, may be of clin